Cerity Partners LLC increased its position in shares of Xylem Inc. (NYSE:XYL – Free Report) by 2.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 339,738 shares of the industrial products company’s stock after purchasing an additional 8,024 shares during the period. Cerity Partners LLC owned 0.14% of Xylem worth $50,111,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of the company. Hanson & Doremus Investment Management increased its holdings in shares of Xylem by 0.9% during the 2nd quarter. Hanson & Doremus Investment Management now owns 8,516 shares of the industrial products company’s stock worth $1,102,000 after buying an additional 77 shares during the last quarter. Princeton Global Asset Management LLC increased its stake in Xylem by 2.1% during the second quarter. Princeton Global Asset Management LLC now owns 3,801 shares of the industrial products company’s stock worth $492,000 after acquiring an additional 79 shares during the last quarter. Private Trust Co. NA raised its position in Xylem by 22.4% in the third quarter. Private Trust Co. NA now owns 459 shares of the industrial products company’s stock valued at $68,000 after purchasing an additional 84 shares during the period. Ascent Wealth Partners LLC lifted its stake in shares of Xylem by 0.6% in the 3rd quarter. Ascent Wealth Partners LLC now owns 14,385 shares of the industrial products company’s stock valued at $2,122,000 after purchasing an additional 87 shares during the last quarter. Finally, Apollon Wealth Management LLC grew its holdings in shares of Xylem by 0.5% during the 3rd quarter. Apollon Wealth Management LLC now owns 17,913 shares of the industrial products company’s stock worth $2,642,000 after purchasing an additional 92 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several analysts recently issued reports on XYL shares. Barclays reduced their price objective on shares of Xylem from $172.00 to $166.00 and set an “overweight” rating on the stock in a report on Wednesday. Weiss Ratings restated a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. TD Cowen lifted their target price on shares of Xylem from $130.00 to $135.00 and gave the company a “hold” rating in a report on Friday, December 5th. Zacks Research cut Xylem from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Finally, Citigroup raised their price target on Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Eight analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $165.80.
Xylem Price Performance
Xylem stock opened at $139.46 on Thursday. The company has a quick ratio of 1.50, a current ratio of 1.96 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $154.27. The firm has a market cap of $33.95 billion, a PE ratio of 35.85, a price-to-earnings-growth ratio of 2.00 and a beta of 1.17. The company’s 50 day moving average is $141.52 and its two-hundred day moving average is $140.53.
Xylem (NYSE:XYL – Get Free Report) last posted its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. The business had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The company’s revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.11 earnings per share. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, research analysts expect that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date was Tuesday, November 25th. Xylem’s dividend payout ratio (DPR) is presently 41.13%.
Insider Transactions at Xylem
In other Xylem news, Director Victoria D. Harker sold 1,700 shares of the business’s stock in a transaction that occurred on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the transaction, the director owned 16,875 shares in the company, valued at $2,499,862.50. The trade was a 9.15% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Claudia S. Toussaint sold 10,421 shares of the stock in a transaction that occurred on Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the sale, the executive vice president directly owned 31,250 shares in the company, valued at approximately $4,770,000. This represents a 25.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.27% of the company’s stock.
About Xylem
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Further Reading
- Five stocks we like better than Xylem
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
